$PROG That's why you need new VP. Drug delivery device has cleared the safety protocol. Now you need to manufacture these devices to start clinical studies of Adalimumab (Humira). New VP will be handling this 10B worth drug. You are dummies if you still can't see partnership with AbbVie. Also, remember Humira is already approved drug. You do not need to conduct p2, p3 trials. Only data obtained from p1 would be sufficient.